HUT35513A - Solutions of lactates of piperazinyl-quinoline-quinoline- and piperazinyl-azaquinolone-carboxylic acids - Google Patents

Solutions of lactates of piperazinyl-quinoline-quinoline- and piperazinyl-azaquinolone-carboxylic acids

Info

Publication number
HUT35513A
HUT35513A HU843476A HU347684A HUT35513A HU T35513 A HUT35513 A HU T35513A HU 843476 A HU843476 A HU 843476A HU 347684 A HU347684 A HU 347684A HU T35513 A HUT35513 A HU T35513A
Authority
HU
Hungary
Prior art keywords
piperazinyl
quinoline
azaquinolone
lactates
solutions
Prior art date
Application number
HU843476A
Other languages
English (en)
Other versions
HU194733B (en
Inventor
Klaus Grohe
Robert Lammens
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6209428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT35513(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HUT35513A publication Critical patent/HUT35513A/hu
Publication of HU194733B publication Critical patent/HU194733B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU843476A 1983-09-17 1984-09-14 Process for producing lactate solutions of piperazinyl-quinolone- and piperazinyl-azaquinolone-carboxylic acids HU194733B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333719 DE3333719A1 (de) 1983-09-17 1983-09-17 Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren

Publications (2)

Publication Number Publication Date
HUT35513A true HUT35513A (en) 1985-07-29
HU194733B HU194733B (en) 1988-03-28

Family

ID=6209428

Family Applications (1)

Application Number Title Priority Date Filing Date
HU843476A HU194733B (en) 1983-09-17 1984-09-14 Process for producing lactate solutions of piperazinyl-quinolone- and piperazinyl-azaquinolone-carboxylic acids

Country Status (24)

Country Link
US (3) US4705789A (hu)
EP (1) EP0138018B1 (hu)
JP (1) JPS6094910A (hu)
KR (1) KR870001958B1 (hu)
AU (1) AU562507B2 (hu)
CA (1) CA1228547A (hu)
DD (1) DD227882A5 (hu)
DE (2) DE3333719A1 (hu)
DK (1) DK162811C (hu)
ES (1) ES8607021A1 (hu)
FI (1) FI83286C (hu)
GR (1) GR80364B (hu)
HK (1) HK74789A (hu)
HU (1) HU194733B (hu)
IE (1) IE57905B1 (hu)
IL (1) IL72953A (hu)
NO (1) NO171765C (hu)
NZ (1) NZ209548A (hu)
PL (1) PL144897B1 (hu)
PT (1) PT79206B (hu)
SG (1) SG21489G (hu)
SU (1) SU1384187A3 (hu)
UA (1) UA8025A1 (hu)
ZA (1) ZA847267B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IL80459A (en) * 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids
AU623474B2 (en) * 1989-01-16 1992-05-14 Laboratoire Roger Bellon New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them
JP3153549B2 (ja) * 1989-12-29 2001-04-09 アボツト・ラボラトリーズ キノロンカルボン酸―金属イオン―酸錯体
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
TW254855B (hu) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
ES2127036B1 (es) * 1994-03-21 1999-11-16 Ind Quimica Agropecuaria S A Aducto de norfloxacina soluble en agua.
KR960000223A (ko) * 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
DE19730023A1 (de) * 1997-07-11 1999-01-14 Bayer Ag Hochreine Ciprofloxacin-Infusion
IN186245B (hu) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CA2310433A1 (en) 1998-09-18 2000-03-30 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparation containing pyridonecarboxylic acid and production method thereof
DE102004005186B3 (de) * 2004-02-02 2005-10-13 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von gereinigtem Ciprofloxacin
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
JP5002462B2 (ja) * 2004-12-09 2012-08-15 バイエル・アニマル・ヘルス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 酸によるグルココルチコイドエステルの安定化
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
MX2011012134A (es) 2009-05-15 2012-02-08 Redx Pharma Ltd Derivados de farmaco de oxido-reduccion.
CN103479569A (zh) * 2013-01-14 2014-01-01 四川喜亚动物药业有限公司 兽用环丙沙星注射液及其制备方法
EP3229714B1 (en) 2014-12-09 2022-03-02 Heflin, John, A. Spine alignment system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE296839C (hu) *
CH296839A (de) * 1944-03-14 1954-02-28 Knoll Ag Verfahren zur Herstellung von haltbaren, wässrigen Lösungen von Salzen von Strychninoxyd.
DE2047486A1 (de) * 1970-09-26 1972-03-30 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Stabilisierung einer pynthioxinhaltigen, wässerigen Injektions lösung
US4022894A (en) * 1975-03-03 1977-05-10 Fainberg Samuel M Stable solution of benzthiazide (3-[benzythiol methyl]-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide) suitable for parenteral administration and process of preparation
JPS6019910B2 (ja) * 1979-10-11 1985-05-18 大塚製薬株式会社 ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸誘導体及びその製造法
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5531028A (en) * 1978-08-25 1980-03-05 Dai Ichi Seiyaku Co Ltd Injection
DE2918319A1 (de) * 1979-05-07 1980-11-13 Roehm Pharma Gmbh Therapeutische verabreichungsform
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS57188515A (en) * 1981-05-13 1982-11-19 Kyoto Yakuhin Kogyo Kk Stabilized aqueous dopamine preparation
ES8304117A1 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".

Also Published As

Publication number Publication date
EP0138018B1 (de) 1988-11-02
PT79206B (en) 1986-08-14
EP0138018A2 (de) 1985-04-24
KR870001958B1 (ko) 1987-10-23
DK441084A (da) 1985-03-18
IE57905B1 (en) 1993-05-05
AU562507B2 (en) 1987-06-11
UA8025A1 (uk) 1995-12-26
HK74789A (en) 1989-09-22
US4705789A (en) 1987-11-10
US4808583A (en) 1989-02-28
US4808585A (en) 1989-02-28
NO171765B (no) 1993-01-25
KR850002096A (ko) 1985-05-06
CA1228547A (en) 1987-10-27
SG21489G (en) 1989-09-22
SU1384187A3 (ru) 1988-03-23
IL72953A0 (en) 1984-12-31
ES8607021A1 (es) 1986-05-16
DE3333719A1 (de) 1985-04-04
DK441084D0 (da) 1984-09-14
DK162811C (da) 1992-05-04
JPH0559893B2 (hu) 1993-09-01
NO843518L (no) 1985-03-18
DD227882A5 (de) 1985-10-02
FI83286B (fi) 1991-03-15
PL249591A1 (en) 1987-03-09
ES535832A0 (es) 1986-05-16
ZA847267B (en) 1985-05-29
DE3474915D1 (en) 1988-12-08
HU194733B (en) 1988-03-28
EP0138018A3 (en) 1986-10-08
FI843587L (fi) 1985-03-18
IL72953A (en) 1988-01-31
AU3297684A (en) 1985-03-21
NZ209548A (en) 1987-02-20
PT79206A (en) 1984-10-01
NO171765C (no) 1993-05-05
GR80364B (en) 1985-01-14
JPS6094910A (ja) 1985-05-28
FI83286C (fi) 1991-06-25
IE842347L (en) 1985-03-17
PL144897B1 (en) 1988-07-30
DK162811B (da) 1991-12-16
FI843587A0 (fi) 1984-09-13

Similar Documents

Publication Publication Date Title
HUT35513A (en) Solutions of lactates of piperazinyl-quinoline-quinoline- and piperazinyl-azaquinolone-carboxylic acids
DE3475520D1 (en) Metal salts of lower dialkylphosphorodithioic acids
GB8313321D0 (en) Preparation of mercaptan substituted carboxylic acids
DE3470415D1 (en) Acid salts of valproic acid
JPS57192325A (en) Manufacture of alpha-arylalkanoic acids and precurcors therefor
EP0114734A3 (en) Pyridinylmethylamino-arylic acids
GB8420234D0 (en) Hydrazides of aminopolyacetic acids
DE3465188D1 (en) Acid salts of valproic acid
IL75811A (en) Preparation of quinolone-and naphthyridone-carboxylic acids
JPS57212158A (en) Manufacture of s-arylthioglycolic acids
EP0130007A3 (en) Preparation of amino-polyols
IL73023A0 (en) Preparation of 2-chloro-benzoxazoles
GB8416629D0 (en) Preparation of 3 11-dimethyl-2-nonacosanone
DE3460618D1 (en) Process for the preparation of fluorocarboxylic acids
GB8418525D0 (en) Preparation of azetidinone sulfinic acids
GB8314001D0 (en) Preparation of alphahaloalkyl esters
IL73787A (en) Preparation of 2-haloresorcinols
GB8401278D0 (en) Preparation of cyanotetrachlorobenzenes
HK74987A (en) Esters of 2-carbamoyloxymethyl-6-hydroxyethyl-2-penem-3-carboxylic acid
GB2137621B (en) Preparation of 1-naphthol-4-sulphonic acid
GB8403962D0 (en) Preparation of aryloxybenzoic acids
GB2110665B (en) Preparation of aminocyclopentanealkenoic acids
GB8418958D0 (en) Aryloxybenzoic acids
GB8412495D0 (en) Aryloxybenzoic acids
GB2120241B (en) Production of hydroxymethylbutenoic acids

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: BAYER HEALTHCARE AG., DE

HPC4 Succession in title of patentee

Owner name: BAYER HEALTHCARE AG., DE